Recent Posts
- Children Respond Differently to Different Learning Rewards
- FAST Launching 24-hour Provider-to-provider Seizure Hotline
- US Angelman Nonprofits Create Working Group for Legislative Advocacy
- To Redefine Angelman Syndrome, We Play the Game by Our Own Rules
- Ovid to Focus on OV882, Potential RNA Therapy for Angelman
- Quick Approval Given COVID Vaccines Raise Concerns, Rare Disease Patients Say
- EveryLife Scholarship Fund Open Until May 7 for Adults With Rare Diseases in US
- Ionis Plans to Launch Clinical Trial This Year for ION582
- Cannabinoid BIO017 Receives FDA’s Orphan Drug Status
- Cost of Rare Diseases in US? Nearly $1 Trillion in 2019, EveryLife Foundation Finds